GlaxoSmithKline Plc is in exclusive talks to sell its Indian Horlicks nutrition business to Unilever Plc, putting an end to an auction that is expected to fetch more than $4 billion, Financial Times reported on Tuesday. GlaxoSmithKline beat a rival bid from Swiss rival Nestle which was also bidding for the unit and looking to expand its portfolio in the powdered hot beverages category, the report added. In September, sources had told Reuters that Nestle, Unilever and Coca-Cola were among bidders for GSK's Indian Horlicks nutrition business and that Nestle was particularly ...
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them. You can change your Cookie Settings at any time but parts of our site will not function correctly without them.
This article is no longer available in our repository.
There could be multiple reasons for this.
You could try searching for this headline on the source website (reuters.com).